Takeda Pharmaceutical Company Limited Form 20-F: Annual report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-06-17: Form 20-F; Period of report 2026-03-31; Description 20-F; Document tak-20260331.htm.
- 2025-06-25: Form 20-F; Period of report 2025-03-31; Description 20-F; Document tak-20250331.htm.
- 2024-06-26: Form 20-F; Period of report 2024-03-31; Description FORM 20-F; Document tak-20240331.htm.
- 2023-06-28: Form 20-F; Period of report 2023-03-31; Description FORM 20-F; Document tak-20230331.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-06-17 | 20-F | 2026-03-31 | 20-F | tak-20260331.htm |
| 2025-06-25 | 20-F | 2025-03-31 | 20-F | tak-20250331.htm |
| 2024-06-26 | 20-F | 2024-03-31 | FORM 20-F | tak-20240331.htm |
| 2023-06-28 | 20-F | 2023-03-31 | FORM 20-F | tak-20230331.htm |
| 2022-06-29 | 20-F | 2022-03-31 | FORM 20-F | tak-20220331.htm |
| 2021-06-29 | 20-F | 2021-03-31 | 20-F | tak-20210331.htm |
| 2020-06-24 | 20-F | 2020-03-31 | 20-F | takeda_20200331x20-f.htm |
| 2019-06-27 | 20-F | 2019-03-31 | 20-F | takeda20-f.htm |